Development of the protocol
Since its original invention in the 1990s, laser microdissection technology has evolved substantially, with the development of several commercially available dissection instruments and the incorporation of computerized platforms and image analysis software [1] [2] [3] [4] . In parallel, protocols for analyzing small amounts of DNA, RNA and protein have improved, facilitating quantitative and in-depth analysis of cellular genomes, transcriptomes and proteomes [5] [6] [7] [8] [9] [10] . Current laser-based instruments have successfully advanced the molecular pathology field, and microdissection studies are now routinely used by a wide spectrum of laboratory-and clinic-based researchers. However, this field has certain challenges, such as the need for improved precision and the requirement for relatively large amounts of biomolecules for some downstream analysis platforms.
Expression microdissection (xMD) represents a conceptual and practical advance that offers substantive improvements for laser dissection based on operator-independent selection of cells using molecular targeting 11 . For xMD, a clear ethylene vinyl acetate (EVA) film is applied to a histological slide containing immunohistochemically (IHC) stained cells and exposed to a light source that irradiates the entire tissue section (Fig. 1a) . The light energy is absorbed by the chromogen, causing focal heat activation of the dissection film and bonding it to target cells. Removal of the film from the histological section procures immunostained cells for subsequent molecular analysis.
Our original proof-of-concept xMD publication used a PixCell II laser microscope for dissections, as well as a prototype instrument with a motorized stage and a fixed 400-mW laser source, using clear EVA films that were modified in-house at the NIH 11 . Tissues processed with various fixatives were analyzed in the initial study, including formalin-fixed, paraffin-embedded (FFPE) samples; ethanol-fixed, paraffin-embedded (EFPE) specimens; and cryopreserved tissue. Targeting probes included antibodies against proliferating cell nuclear antigen, cytomegalovirus, cytokeratin AE1/ AE3, CD3, prostate-specific antigen, desmin, S-100, glyceraldehyde 3-phosphate dehydrogenase, E-cadherin and smooth muscle actin. In a second xMD study, we used a PixCell II system and in-house xMD films to dissect smooth muscle actin-positive and cytokeratin AE1/AE3-positive cells for subsequent epigenetic analysis, and then a third study used a similar xMD strategy and targeting antibodies against CD31 and Factor VIII to analyze endothelial cells in normal and cancerous tissue 12, 13 . The protocol presented here is based on these previous studies, but it has been adapted to several different laser sources to make xMD technology accessible to the biomedical research community.
Comparison with other methods
As opposed to xMD, standard laser capture microdissection (LCM) is based on visual identification of target cells through a microscope 1, 2 . A histological section is stained, and then a dye-containing EVA thermoplastic polymer is applied onto the slide (Fig. 1b) . An IR laser is activated under microscopic visualization and aimed at cells under the operator's guidance. The light energy is absorbed by the dye in the polymer causing it to partially melt and bond to the targets 1, 2, 14 . Subsequent removal of the dissection film from the tissue procures the bonded cells and they are placed into an appropriate buffer for molecular analysis. For both xMD and standard LCM, the IR energy is mostly absorbed by the chromogen or dye and not by the tissue; thus, there is little or no damage to the cells and the quality of the recovered biomolecules is related to the effects of upstream tissue processing and not to the dissection process itself 1, 2, [14] [15] [16] . Immuno-based laser dissection is a follow-on technique developed by Fend et al. 17 that uses immunotargeting to improve visualization of cells of interest. In this approach, IHC or Expression microdissection adapted to commercial laser dissection instruments immunofluorescence is used as a visualization tool to identify specific cells that the laser operator then procures under microscopic visualization in a one-by-one manner. More recently, the incorporation of image analysis programs into laser microscopes has facilitated dissection of immunolabeled target cells via automatic recognition software; however, visual identification of positive cells by a human operator is typically needed to ensure proper cell selection. Immuno-based laser dissection has been used for numerous published articles, including epigenetic analysis, tumor microenvironment studies and neuroscience research [17] [18] [19] [20] [21] [22] [23] [24] [25] . Moreover, improved IHC protocols allow for the use of specialized types of films such as polyethylene naphthalate membrane slides 22 . The adaptation of xMD to available instruments provides a new dissection tool for investigators studying phenotype or molecularly defined cells in histological sections. Our expectation is that xMD will extend microdissection capability into new areas of biological inquiry and that the technique will be complementary to, rather than competitive with, existing approaches. There are two important advantages of xMD that facilitate dissection-based analyses: precision and throughput.
The precision of microdissection using xMD is improved because of the unique physical properties of film-cell interaction. As activation of EVA is strictly a consequence of the focal temperature increase generated by the adjacent chromogen on target cells (as opposed to the size of the targeting laser beam in standard laser dissection), the area of activation and subsequent capture are reduced, thus allowing a higher resolution microdissection such as endothelial cells or nuclei 11, 13 . Importantly, because xMD is based on a probe for dissection, all targeted cells or targeted organelles are rapidly procured in an operator-independent manner. In contrast, performing precise dissections using standard laser microscopes is an extremely challenging and tedious process that, even when successful, recovers only a few targets and scant biomolecules with limited use in molecular assays. Because xMD can procure all of the probe-targeted cells or organelles in a histological section, whether it contains 10 targets or 10 6 targets, relatively large amounts of DNA, RNA or protein can be generated from precisely dissected cells or organelles.
With respect to throughput, standard laser dissection and immuno-LCM work well for downstream molecular assays that either require small amounts of input material or are nucleic-acid based and amenable to amplification methods. For many assays, though, a significant increase in the number of dissected cells is advantageous; proteomic analysis is one such example 4 . Moreover, even for amplification-based protocols the general rule of thumb in the dissection field is 'the more cells the better' , as the molecular data are typically improved as the amount of starting material increases, and the depth of the analysis is increased as more moderate-and low-abundant molecules can be measured. Thus, even some amplification-based studies (except for mRNA from cryosections, see below) may be improved by taking advantage of the high-throughput capability of xMD, especially when performed in concert with an automated immunostaining instrument that rapidly processes slides.
However, an important caveat for xMD technology is the effect that IHC staining has on the biomolecules in tissue sections 24, 25 . The immunostaining process includes several incubation and wash steps, followed by enzymatic-based colorimetric labeling. Currently, xMD can be successfully applied to DNA analysis, proteomics and to the study of mRNA and microRNA in archival samples; however, measurement of mRNA in frozen tissue sections is compromised by the immunostaining procedure and is challenging to perform using any of the immuno-based dissection techniques (see Box 1) 24, 25 . Although this is a limitation of the current xMD method, this difficulty is mitigated for investigators by the availability of transcriptome amplification methods that can be used to analyze a b 
Box 1 | ExTRACTIoN FRoM xMD FILMS
Standard buffers and kits used for laser-microdissected samples can be used to extract captured tissue from xMD films. The exact buffer or kit depends on the biomolecule(s) of interest and the method of tissue preservation.
• For DNA, we use the QIAamp DNA Micro kit (Qiagen).
• For RNA extraction, we use the PicoPure kit (Life Technologies).
• For denatured protein analysis (1D-PAGE), we use the Novex Tris-glycine SDS sample buffer (2×; Life Technologies) with gentle heating (55 °C) and agitation. Do not heat the film in the SDS buffer above 80 °C because the film will melt and compromise sample recovery.
• For mild protein analysis (2D-PAGE), we use the Total Protein Isolation Kit (ITSI Biosciences); however, note that the recovery of proteins from immunostained tissue sections varies depending on the tissue type and staining method. In general, protein profiling after xMD is better accomplished using mass spectrometry.
• For protein mass spectrometry, we use a protocol described by Johann et al. 9 .
• Following xMD, the ethylene vinyl acetate film with transferred cells should be placed into a 1.5-ml Eppendorf tube containing sufficient extraction buffer to cover the film while incubating the tube with regular agitation using an Eppendorf themomixer or an orbital heater.
the small number of cells procured in a standard laser dissection study. The unique niche for xMD is likely to be microRNA and mRNA measurements from archival FFPE samples in which a substantive increase in starting material, of an order of magnitude or more, is often required (beyond that used for frozen sections) because of the fragmentation of nucleic acids that occurs during the upstream tissue processing steps. Ultimately, investigators need to select the proper dissection tool for their particular study on the basis of the goals of the analysis, the abundance level of the molecule(s) of interest, the number of target cells in the tissue available for dissection and the quality of specimens related to tissue processing. In the LCM Core Laboratory at NIH, we routinely recommend that investigators perform a set of pilot tests on their samples before commencing a large study to assess each variable and select the proper dissection strategy.
Experimental design
In this paper, we describe protocols for using xMD technology on three commercially available laser dissection instruments and on a handheld laser device. The specific goal was to adapt xMD to them with minimal modifications. Among the commercial dissection instruments we tested, the Arcturus XT and Veritas systems are preferred because their motorized stages and auto-selection software facilitate the rapid irradiation of whole slides.
Slide preparation and immunohistochemistry. Similar to standard laser dissection, xMD can be used to recover cells from histological sections of frozen tissue or from paraffinembedded tissue fixed with formalin or ethanol. The microtome-or cryosections should be mounted on a charged slide (see PROCEDURE for more details) and IHC stained with chromogen 3,3′-diaminobenzidine (DAB) 11 . The slide should not be counterstained afterward and no cover slip should be placed on the tissue section before xMD. The general rule of thumb regarding IHC intensity is that strongly stained cells will be efficiently dissected, but weakly stained cells or any cells or organelles with a 'blush background' will generally not be procured. There is a distinct threshold of film activation that requires strong staining; therefore, the primary antibody concentration used for IHC should be titrated accordingly.
Preparation of the EVA polymer. To improve cell dissection efficiency, we tested variations in film-tissue pressure and film preheating, as good contact between the EVA polymer and the tissue section is essential for xMD. For the original prototype instrument at NIH, we accomplished this by using an air-bearing jet near the laser diode output that served to mechanically enhance contact of the film overlaying the tissue with the cells to be dissected. However, as we wanted to adapt xMD technology to standard laser instruments and devices without making substantive changes in them, we tested two strategies to improve the EVA/tissue contact: first, application of pressure, and second, application of heat. The increased malleability of EVA from heating the polymer films, combined with the use of gentle pressure applied using a roller, proved to be the optimal means to ensure close contact with the tissue (see PROCEDURE for additional details). The best heating conditions for pretreatment of the EVA polymer include a temperature ranging from 60 °C to 80 °C for 2-5 min, although the optimal temperature and time vary depending on the composition of the EVA film (see PROCEDURE and Box 2). As shown in Figure 2 , this approach allowed selective capture of breast cancer cells immunolabeled with antibodies against estrogen receptors (Fig. 2a-e) and dissection of prostate epithelium using targeting of cytokeratin AE1/AE3 (Fig. 2f,g ). With a relatively low laser power, target cells were precisely bonded to the film, resulting in a high-resolution dissection.
Laser parameters. For each laser source, various parameters were tested, including power levels and duration of the laser pulse. Overall, xMD can be performed with settings available in all tested instruments, usually requiring longer pulse duration times (between 15 and 50 ms) and a higher overlap (50%) of the pulses than in conventional laser dissection, with power settings dependent on the type of target cells (see PROCEDURE). In general, optimal laser parameters for xMD using LCM systems range from 30 to 75 mW. PixCell II and Veritas require manual focus adjustment of the IR laser, in conjunction with a Macro Cap stripped of its original film and placed on the slide for xMD. The Arcturus XT instrument does not have manual focus adjustment of the IR laser; however, the plastic cap is still necessary for successful dissection.
For the handheld laser device, we used a commercially available SDL-15 system from Biotechnique Avance. This is an 808 nm wavelength laser 'gun' adapted for xMD to heat darkly stained cells within the tissue (Fig. 3a,b) . By using the premelting step described above to enhance the contact between the film and tissue, we recovered NeuN-stained individual nuclei from frozen rat brain tissue (Fig. 3c,d ) and procured cytokeratin AE1/AE3-positive epithelium from EFPE prostate tissue (Fig. 3e,f) . These experiments demonstrate the speed at which xMD dissections can be completed (10-15 min), as well as precision (nuclei). Moreover, the use of a relatively inexpensive laser system allows dissections to be performed for the first time in an instrument-free, 'kit-like'
Box 2 | EVA FILM FoR xMD
EVA is a copolymer of ethylene and vinyl acetate that has several medical and pharmaceutical applications. The thermoplastic properties of EVA film make it suitable for laser microdissection 14 . For xMD, we initially used a 100-µm-thick DuPont ELVAX 410 EVA polymer extruded onto a paper-release liner as a thermoplastic seam tape (Electroseal) with an optimal heating temperature of 65 °C. However, this source has been discontinued and therefore we are currently using a CoTran membrane (3M, cat. no. 3M CoTran 9715). CoTran 9715 is a translucent EVA membrane containing 19% vinyl acetate; it has a thickness of 76.2 µm and an optimal heating temperature of 75 °C. Depending on the tissue type, target cell and specifics of the dissection process, different EVA films may be required to obtain satisfactory results. In general, the following features are optimal for xMD: • Film thickness 50-100 µm. Note that dissection of small targets may be facilitated with thinner films.
• Optical translucency.
• A concentration of vinyl acetate ~20%. The concentration of vinyl acetate correlates with melting temperature. In our tests, films with higher melting temperatures generally increase the specificity of microdissection.
manner. In other words, the protocol can be performed on any laboratory bench by using xMD films and a low-cost light source. However, it should be noted that handheld xMD is the most recent iteration of the technology; thus, we have the least amount of experience with this version and investigators may need to adapt the protocol (laser pulse duration and power; film contact parameters) to meet their specific needs.
Pilot tests and controls. At the outset of an xMD study, it is important to conduct pilot tests to evaluate the status of biomolecules in samples and to determine optimal dissection conditions, in much the same way as investigators do when using standard laser instruments. At the NIH LCM Core, we recommend assessing biomolecule quality in the tissue section after IHC as a first step, thereby evaluating the effects of both upstream tissue processing (specimen procurement, fixation and embedding) and the immunostaining procedure. The investigator simply scrapes a small amount of tissue from an IHC-stained slide and from a nonstained control section into extraction buffer and analyzes the content according to the assay(s) to be used in the study, evaluating whether the stained tissue is compatible with the analysis method and further determining the approximate number of cells needed. When there are multiple specimens and reasons to believe that there could be differences in biomolecule quality among them, such as a clinical study involving multiple institutions, a scrape test should be performed on all samples. Next, the specific conditions for xMD need to be determined, as optimal laser parameters are dependent on the type of tissue, the size of target cells or structures (smaller ones often require lower laser power) and the specific IHC staining pattern.
Finally, downstream molecular analysis of the dissected cells should use established controls, e.g., those described previously in Nature Protocols by Erickson et al. 8 for mRNA measurements.
Future directions. Looking forward, there are several aspects of xMD technology that are likely to be improved on as more members of the research community gain access to the technique. As one example, future replacement of colorimetric dyes with heatabsorbing nanoparticles is a promising approach to reduce the deleterious effects of immunolabeling, as this will simplify the IHC procedure by removing oxygen free radicals and stain deposition from the protocol. As a second example, the exploration of new EVA polymer films is an exciting area for further development, especially with respect to dissection precision. In this protocol, we used the specific types and sources of EVA film described; however, investigators should not feel constrained by these parameters, and may in fact be able to improve on them by using EVA (or other polymers) from alternative sources or with different properties (see Box 2). The extreme fidelity by which irradiated dyes activate overlying EVA suggests that improvements in dissection precision may be possible, perhaps to the level of small cellular organelles or even discrete molecular complexes, although the parallel use of histological pretreatment steps may be necessary to achieve these goals by altering the force needed to procure minute cellular elements. Certainly, the evolution of xMD technology to this level of resolution would be an exciting advancement, opening up many new lines of investigation of cells in histological sections. The area demarked by blue lines was irradiated using the xMD protocol with an Arcturus XT instrument. Arrows indicate a tumor area that was intentionally not irradiated by the laser. Magnification, ×20; scale bar, 500 µm. (b) The same breast carcinoma section after xMD and removal of the EVA film. Note that, within the irradiated area, only estrogen-positive cells were microdissected, whereas negative regions such as stroma and fibroblasts (demarcated by black arrows) were not captured and remain on the slide. Further, the tumor area that was not irradiated for xMD (white arrows) remains intact. Magnification, ×20; scale bar, 500 µm. (c) Low-magnification view of the same EVA film in panels a and b after xMD. The tumor cells positive for estrogen receptor are selectively captured onto the EVA film. However, the film did not capture the non-stained cells, stroma or the tumor cells within areas that were not irradiated. Magnification, ×20; scale bar, 500 µm. (d) Higher magnification view of the area of cancer cells (from panel b) positive for estrogen receptor that were captured using xMD. Note that negative stroma (black arrows) and cancer cells that were not irradiated (white arrows) remain on the slide. Magnification, ×100; scale bar, 100 µm. (e) EVA polymer from the same area shown in Figure 2d . Only IHC-positive cells were transferred. No stromal cells or unselected areas were captured. Magnification, ×100; scale bar, 100 µm. (f) Anti-cytokeratin AE1/AE3-stained EFPE prostate epithelial tissue that was transferred onto EVA film using the PixCell II instrument. Magnification, ×100; scale bar, 100 µm. (g) Anti-cytokeratin AE1/AE3-stained EFPE prostate epithelial tissue that was transferred onto EVA film using the Veritas instrument. Magnification, ×100; scale bar, 100 µm.
MaterIals

REAGENTS
Frozen, ethanol-fixed or formalin-fixed, paraffin-embedded (FFPE) tissue specimens sectioned at a thickness of 4-12 µm and mounted on glass slides 
Box 3 | PREPARATIoN oF A MACRo LCM CAP FoR PERFoRMING xMD
When performing xMD using the Arcturus XT , Veritas or PixCell II systems, the laser must reach the proper focal plane at the surface of the tissue. This is achieved with optical plastic backing of a Macro LCM cap (Life Technologies). However, commercially available LCM caps contain a dyed film that must be removed before xMD. The following simple procedure is used:
• While you are wearing gloves, carefully remove a cap from its plastic tray.
• With cleaned forceps, pull the plastic film from the cap.
• Clean the plastic surface of the cap with lens paper soaked in 70% (vol/vol) ethanol.
• Carefully replace the cap in the original plastic tray.
• Note: the prepared cap can be reused during the xMD procedure.
Box 4 | LASER SAFETY PRECAUTIoNS
All the commercially available laser dissection instruments described here (Arcturus XT , Veritas, PixCell II) have enclosed lasers; therefore, no additional safety precautions are necessary for the expression microdissection (xMD) protocol. However, the handheld xMD device is an 'open' laser source and thus requires the following safety measures:
• All users must wear appropriate-wavelength laser safety goggles with an optical density (OD) value higher than 7 in the 808-nm range.
• All users should also wear lab coats and latex gloves.
• The laser should be housed in a lockable room with appropriate 'warning' signage.
• All windows and other openings of the room must be covered to prevent accidental exposure to individuals.
• An acrylic box structure should be used to house the laser and the slide to prevent accidental exposure. One example is a laser safety dome by Laservision (cat. no. 1307, dome filter pink (OD > 7 at 755-830 nm)).
• The work area should be free of reflective surfaces that could cause accidental exposure.
• Before you use the handheld laser device, a laser safety representative should evaluate the work environment. proceDure slide preparation for xMD • tIMInG 2 h 20 min to 1 d (depending on incubation time) 1| Stain the slide by IHC using a primary antibody of choice. An example IHC protocol is provided in Box 5. ! cautIon All animal tissues must be obtained according to relevant guidelines and regulations. All human tissue samples must be obtained according to institutional review board protocols, including informed consent from subjects.  crItIcal step Do not counterstain the tissue with hematoxylin or other stains following IHC. Do not place a cover slip on the stained tissue section.  crItIcal step If RNA or proteins are to be extracted, we recommend performing xMD immediately after IHC staining.  pause poInt If DNA extraction is to be performed, the stained slides can be stored in a tightly closed jar containing desiccant, avoiding direct light exposure. The slides can be used safely within 1 week. ? trouBlesHootInG 2| With a razor blade, cut a section of EVA film that is sufficient to cover the tissue section, but that is slightly narrower than the width of the slide. This is important to ensure that EVA on the slide fits in the slide holder of the automated instruments.
3| With forceps, you should carefully place the trimmed EVA polymer on the tissue section.
4| Apply the sealing roller with uniform pressure across the EVA film on the slide.  crItIcal step This is necessary to ensure good contact between the EVA film and the tissue.
5|
Place the slide with the EVA film on a hot plate or into a hybridization chamber set at 60-80 °C for 2-5 min.  crItIcal step The optimal heating temperature needs to be predetermined by the user and depends on the type of EVA film used (see Box 2). ? trouBlesHootInG 6| Apply the roller to the EVA polymer surface using gentle and uniform pressure.  crItIcal step Because the EVA film is warm and malleable, contact between the film and the tissue is further improved. ? trouBlesHootInG 7| Allow the slide with the EVA film to cool at room temperature (20-25 °C) for 5 min. The slide is now ready for xMD.  crItIcal step Once the EVA film has adhered to the slide, it is our experience that it is best to proceed immediately to xMD. ? trouBlesHootInG xMD process • tIMInG 10-60 min per slide, depending on the laser system used 8| xMD can be performed using option A (Arcturus XT ), option B (Veritas) or option C (Pixcell II) as described below. Furthermore, the protocol can be performed using option D, a handheld laser system that does not require a laser microdissection instrument. ? trouBlesHootInG
• tIMInG
Step 1, Including Box 5: 2 h to overnight (depending on the incubation time needed for the primary antibody). The yield of biomolecules depends on the number of procured cells and on the method of tissue preservation. However, biomolecule recovery can be negatively affected by the IHC staining process; thus, it is important to analyze an IHC-stained tissue section at the outset of a study to obtain an estimate of quality and quantity. In addition, spectrophotometer-based measurement (NanoDrop, Thermo Scientific) of the extracted biomolecules is recommended. coMpetInG FInancIal Interests The authors declare competing financial interests (see the HTML version of this article for details).
